Trellus Health plc
TRLS.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 500% | 5.6% | -28% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | £0 | £0 | £1 | £0 |
| G&A Expenses | £3 | £2 | £9 | £6 |
| SG&A Expenses | £3 | £2 | £9 | £6 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £5 | £5 | -£1 | -£0 |
| Operating Expenses | £8 | £7 | £9 | £6 |
| Operating Income | -£8 | -£7 | -£9 | -£6 |
| % Margin | -7,041.2% | -35,805.3% | -48,944.4% | -23,608% |
| Other Income/Exp. Net | £0 | £0 | £0 | £0 |
| Pre-Tax Income | -£8 | -£6 | -£9 | -£6 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£8 | -£6 | -£9 | -£6 |
| % Margin | -6,826.3% | -33,363.2% | -48,944.4% | -23,608% |
| EPS | -0.048 | -0.039 | -0.055 | -0.045 |
| % Growth | -23% | 28.1% | -21.7% | – |
| EPS Diluted | -0.048 | -0.039 | -0.055 | -0.045 |
| Weighted Avg Shares Out | 162 | 162 | 162 | 132 |
| Weighted Avg Shares Out Dil | 162 | 162 | 162 | 132 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £1 | £0 | £1 | £0 |
| EBITDA | -£7 | -£6 | -£8 | -£6 |
| % Margin | -6,281.6% | -34,194.7% | -45,966.7% | -23,480% |